Article
More on ‘treatment resistance’
- Author:
- Stanley N. Caroff, MD
- Bruce J. Schwartz, MD
- Vania Castillo, MD
I wanted to thank Dr. Nasrallah for his bold article, “Treatment resistance is a myth!” (From the Editor, Current Psychiatry, March 2021, p. 14-16...
Article
Tardive dyskinesia is theme of awards competition for early career psychiatrists
- Author:
- Stanley N. Caroff, MD
Dr. Stanley N. Caroff announces details about the 2018 Promising Scholars Program.
Opinion
Tardive dyskinesia is theme of awards competition for early career psychiatrists
- Author:
- Stanley N. Caroff, MD
Dr. Stanley N. Caroff announces details about the 2018 Promising Scholars Program.
Opinion
Depression and deep brain stimulation: ‘Furor therapeuticus redux’
- Author:
- Stanley N. Caroff, MD
Dr. Stanley N. Caroff warns against the overuse of deep brain stimulation for behavioral disorders.
Audio
Steps to take when a patient develops tardive dyskinesia
- Author:
- Stanley N. Caroff, MD
Stanley N. Caroff, MD
News
Is there a rational management strategy for tardive dyskinesia?
- Author:
- Stanley N. Caroff, MD
Decisions should be based on the course of TD and effective control of psychotic symptoms
News
Neuroleptic malignant syndrome: Answers to 6 tough questions
- Author:
- Jeffrey R. Strawn, MD
- Paul E. Keck Jr, MD
- Stanley N. Caroff, MD
Empiric evidence clarifies risk factors, causes, and first-line interventions.
News
Beware ictal activity that mimics psychiatric illness
- Author:
- Joseph S. Goveas, MD
- Stanley N. Caroff, MD
- Silvana Riggio, MD
How to detect and halt nonconvulsive status epilepticus.
News
Neuroleptic malignant syndrome: Still a risk, but which patients may be in danger?
- Author:
- Stanley N. Caroff, MD
Hyperthermic reactions, though rare, can occur with any antipsychotic. Knowing the risk factors and early warning signs remains important to...